Payer+Provider's Health System Review
3 revenue cycle leaders on their hospital’s biggest concern now that standard charges are public
‘Netflix’ model for pricing hep. C drugs expected to lower patient costs by 85% in Australia
February 18, 2019
Read the full post on Becker's Hospital Review
